Pharmaceuticals in Hungary

Date: April 30, 2014
Pages: 34
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: PEAD51519ECEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Hungary
Pharmaceuticals in Hungary industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Hungary pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.
  • The Hungarian pharmaceuticals market had total revenues of $1.8bn in 2013, representing a compound annual rate of change (CARC) of -3.9% between 2009 and 2013.
  • Government austerity policies designed to curb health care expenditure have had a significant effect on growth in the Hungarian pharmaceutical market.
  • The performance of the market is forecast to accelerate, with an anticipated CAGR of 1.4% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $2.0bn by the end of 2018.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Hungary

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Hungary

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Hungary pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Hungary economy

Key Questions Answered
  • What was the size of the Hungary pharmaceuticals market by value in 2013?
  • What will be the size of the Hungary pharmaceuticals market in 2018?
  • What factors are affecting the strength of competition in the Hungary pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Hungary's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
EGIS Pharmaceuticals Plc
Gedeon Richter Plc
Novartis AG
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Hungary pharmaceuticals market value: $ billion, 2009–13
Table 2: Hungary pharmaceuticals market geography segmentation: $ billion, 2013
Table 3: Hungary pharmaceuticals market share: % share, by value, 2013
Table 4: Hungary pharmaceuticals market value forecast: $ billion, 2013–18
Table 5: EGIS Pharmaceuticals Plc: key facts
Table 6: EGIS Pharmaceuticals Plc: key financials ($)
Table 7: EGIS Pharmaceuticals Plc: key financials (HUF)
Table 8: EGIS Pharmaceuticals Plc: key financial ratios
Table 9: Gedeon Richter Plc: key facts
Table 10: Gedeon Richter Plc: key financials ($)
Table 11: Gedeon Richter Plc: key financials (HUF)
Table 12: Gedeon Richter Plc: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Hungary size of population (million), 2009–13
Table 17: Hungary gdp (constant 2000 prices, $ billion), 2009–13
Table 18: Hungary gdp (current prices, $ billion), 2009–13
Table 19: Hungary inflation, 2009–13
Table 20: Hungary consumer price index (absolute), 2009–13
Table 21: Hungary exchange rate, 2009–13

LIST OF FIGURES

Figure 1: Hungary pharmaceuticals market value: $ billion, 2009–13
Figure 2: Hungary pharmaceuticals market geography segmentation: % share, by value, 2013
Figure 3: Hungary pharmaceuticals market share: % share, by value, 2013
Figure 4: Hungary pharmaceuticals market value forecast: $ billion, 2013–18
Figure 5: Forces driving competition in the pharmaceuticals market in Hungary, 2013
Figure 6: Drivers of buyer power in the pharmaceuticals market in Hungary, 2013
Figure 7: Drivers of supplier power in the pharmaceuticals market in Hungary, 2013
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Hungary, 2013
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Hungary, 2013
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Hungary, 2013
Figure 11: EGIS Pharmaceuticals Plc: revenues & profitability
Figure 12: EGIS Pharmaceuticals Plc: assets & liabilities
Figure 13: Gedeon Richter Plc: revenues & profitability
Figure 14: Gedeon Richter Plc: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities


Skip to top


OTC Pharmaceuticals in Hungary US$ 350.00 Sep, 2014 · 35 pages
The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages

Ask Your Question

Pharmaceuticals in Hungary
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: